Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1997-11-21
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0248-8663
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
18
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
732-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9365728-Adenocarcinoma,
pubmed-meshheading:9365728-Aged,
pubmed-meshheading:9365728-Androgen Antagonists,
pubmed-meshheading:9365728-Bone Neoplasms,
pubmed-meshheading:9365728-Humans,
pubmed-meshheading:9365728-Male,
pubmed-meshheading:9365728-Prostate-Specific Antigen,
pubmed-meshheading:9365728-Prostatic Neoplasms,
pubmed-meshheading:9365728-Substance Withdrawal Syndrome
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
[Antiandrogen withdrawal syndrome in hormone refractory metastatic prostate cancer].
|
| pubmed:publicationType |
Letter,
Case Reports
|